FdaApplication
NDA 207975
Identifiers
- fda_app_no: NDA207975
Properties
| Property | Value |
|---|---|
| applicant_name | TEVA BRANDED PHARMACEUTICAL PRODUCTS R AND D INC |
| application_type | NDA |
| approval_date | 2017-01-17 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| VANTRELA ER | HYDROCODONE BITARTRATE | 60MG | TABLET, EXTENDED RELEASE;ORAL |
| VANTRELA ER | HYDROCODONE BITARTRATE | 90MG | TABLET, EXTENDED RELEASE;ORAL |
| VANTRELA ER | HYDROCODONE BITARTRATE | 30MG | TABLET, EXTENDED RELEASE;ORAL |
| VANTRELA ER | HYDROCODONE BITARTRATE | 45MG | TABLET, EXTENDED RELEASE;ORAL |
| VANTRELA ER | HYDROCODONE BITARTRATE | 15MG | TABLET, EXTENDED RELEASE;ORAL |
5 products